Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-06
2:08 pm
Sale
13GBiondVax Pharmaceuticals Ltd.
BVXV
STONE DANIEL E.298,150
8.4%
-37,190,370decrease
(-99.20%)
View
2023-01-04
09:21 am
Purchase
13GBiondVax Pharmaceuticals Ltd.
BVXV
SABBY MANAGEMENT LLC228,329
11%
228,329increase
(New Position)
View
2022-12-27
09:04 am
Unchanged
13DBiondVax Pharmaceuticals Ltd.
BVXV
NACHT MARIUS170,961,770
12.3%
0
(Unchanged)
View
2022-10-06
10:23 am
Purchase
13GBiondVax Pharmaceuticals Ltd.
BVXV
STONE DANIEL E.37,488,520
5.02%
37,488,520increase
(New Position)
View
2022-01-11
12:47 pm
Unchanged
13DBiondVax Pharmaceuticals Ltd.
BVXV
NACHT MARIUS170,961,770
23.6%
0
(Unchanged)
View
2021-02-09
06:01 am
Unchanged
13DBiondVax Pharmaceuticals Ltd.
BVXV
NACHT MARIUS170,961,770
30.6%
0
(Unchanged)
View
2020-01-24
4:15 pm
Unchanged
13GBiondVax Pharmaceuticals Ltd.
BVXV
Ibex Investors LLC14,360,000
3.6%
0
(Unchanged)
View
2019-11-12
06:08 am
Purchase
13DBiondVax Pharmaceuticals Ltd.
BVXV
NACHT MARIUS170,961,770
42.49%
117,200,938increase
(+218.00%)
View
2019-01-28
4:42 pm
Unchanged
13GBiondVax Pharmaceuticals Ltd.
BVXV
Ibex Investors LLC14,360,000
5.5%
0
(Unchanged)
View